DK1157041T3 - Antistoffer til diagnose og behandling af cancer - Google Patents

Antistoffer til diagnose og behandling af cancer

Info

Publication number
DK1157041T3
DK1157041T3 DK00912115T DK00912115T DK1157041T3 DK 1157041 T3 DK1157041 T3 DK 1157041T3 DK 00912115 T DK00912115 T DK 00912115T DK 00912115 T DK00912115 T DK 00912115T DK 1157041 T3 DK1157041 T3 DK 1157041T3
Authority
DK
Denmark
Prior art keywords
antibodies
diagnosis
cancer
treatment
Prior art date
Application number
DK00912115T
Other languages
English (en)
Inventor
Paul J Carter
John B Ridgway
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Priority claimed from PCT/US2000/005352 external-priority patent/WO2000052054A2/en
Application granted granted Critical
Publication of DK1157041T3 publication Critical patent/DK1157041T3/da

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57423—Specifically defined cancers of lung
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2896—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against molecules with a "CD"-designation, not provided for elsewhere
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/3023—Lung
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
    • C07K2317/62—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
    • C07K2317/622—Single chain antibody (scFv)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/30—Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto
DK00912115T 1999-03-01 2000-02-29 Antistoffer til diagnose og behandling af cancer DK1157041T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US12226299P 1999-03-01 1999-03-01
PCT/US2000/005352 WO2000052054A2 (en) 1999-03-01 2000-02-29 Antibodies for cancer therapy and diagnosis
EP00912115A EP1157041B1 (en) 1999-03-01 2000-02-29 Antibodies for cancer therapy and diagnosis

Publications (1)

Publication Number Publication Date
DK1157041T3 true DK1157041T3 (da) 2005-10-03

Family

ID=35004935

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00912115T DK1157041T3 (da) 1999-03-01 2000-02-29 Antistoffer til diagnose og behandling af cancer

Country Status (3)

Country Link
EP (1) EP1591456A1 (da)
DK (1) DK1157041T3 (da)
SI (1) SI1157041T1 (da)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN117229424B (zh) * 2023-11-13 2024-02-20 南京医科大学 一种靶向cd55的嵌合抗原受体及其应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0223842A4 (en) * 1985-05-24 1987-08-24 Univ New York MONOCLONAL ANTIBODY AGAINST DECAY ACCELERATION FACTOR, THEIR PRODUCTION AND USE.
AU751659B2 (en) * 1997-05-02 2002-08-22 Genentech Inc. A method for making multispecific antibodies having heteromultimeric and common components
GB9804065D0 (en) * 1998-02-26 1998-04-22 Cancer Res Campaign Tech Tumour associated antigen 791Tgp72

Also Published As

Publication number Publication date
EP1591456A1 (en) 2005-11-02
SI1157041T1 (sl) 2005-12-31

Similar Documents

Publication Publication Date Title
DK0972201T3 (da) Forbindelser til immundiagnosticering af prostatacancer og fremgangsmåder til anvendelse heraf
NO20023402D0 (no) Blandinger og fremgangsmåter for behandling og diagnose av prostatakreft
NO20013002D0 (no) Blandinger og fremgangsmåter for behandling og diagnose av ovariekreft
NO20016427D0 (no) Blandinger og fremgangsmåter for behandling av diagnose av lungekreft
NO20014769D0 (no) Preparat for behandling og diagnose av bryst cancer og fremgangsmåter for anvendelse derav
DK200001852A (da) Manipuleringssektion til et endoskopisk behandlingsinstrument
IS6195A (is) Notkun á mótefnum gegn CD20 til meðhöndlunar á þegahöfnunarveiki
EA200000274A3 (ru) Способы получения и промежуточные соединения для получения противораковых соединений
NO20022592D0 (no) Forbindelser og fremgangsmåter for behandling og diagnose av Chlamydia-infeksjoner
DE59913141D1 (de) Blutbehandlungsgerät
DK1189641T5 (da) Humaniserede ANTI-ErbB2-antistoffer og behandling med ANTI-ErbB2-antistoffer
NO20024972D0 (no) Blandinger og fremgangsmåter for terapi og diagnose av brystkreft
NO20010196D0 (no) Sammensetninger og fremgangsmåter for terapi og diagnose av prostatakreft
DK1587837T3 (da) Epitopsekvenser til diagnose og behandling af prostatacancer
DE60029499D1 (de) Toner und Bildherstellungsverfahren
NO20033387D0 (no) Modifiserte antistoffer og fremgangsmåter for anvendelse
NO983183L (no) Blandinger og fremgangsmåte for behandling og diagnose av brystkreft
DK0971735T3 (da) Fremgangsmåder og præparater til behandling af inflammatorisk tarmsygdom
DE60032066D1 (de) Toner und Bildherstellungsverfahren
DE60030355D1 (de) Toner und Bildherstellungsverfahren
DK1411064T3 (da) Gangliosid-associerede rekombinante antistoffer og anvendelsen deraf i diagnosen og behandlingen af tumorer
NO994932D0 (no) Blandinger og fremgangsmaater for behandling og diagnose av brystkreft
NO20014804L (no) Forbindelser for immunterapi og diagnose av brystkreft og fremgangsmåter for deres anvendelse
DE60032884D1 (de) Blutbehandlungssystem
NO20014805D0 (no) Blandinger og fremgangsmåter for behandling og diagnose av brystkreft